FDA sets the date for hearing on legalising hemp-derived CBD

The US Food and Drug Administration (FDA) has set a tentative date of sometime in April for a long-awaited public meeting to hear from stakeholders and begin a rulemaking process on legalising hemp-derived CBD, according to FDA Commissioner Scott Gottlieb.

The commissioner was peppered with several questions about CBD and food supplements during the House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies hearing on the status of operations at FDA on February 27th.


Restricted content. Do you want to read more?